CCVAC logo

People’s Vaccine Inquiry launches

The People’s Vaccine Inquiry, launched on June 10 2024, features submissions from CCVAC lead Dr Ros Jones, along with other expert witnesses.

The official website for the Inquiry, where you can read the statements and watch video testimony, is below.

CCVAC logo

Letter to Liz Truss from the CCVAC

26th September, 2022

The Rt Hon Liz Truss

The Prime Minister
10, Downing Street,
London, SW1A 2AA 

Dear Ms Truss,

Re: Covid-19 Vaccines for Children

Firstly, congratulations on becoming our new Prime Minister.

You will no doubt have many pressing matters as you take up office.  But what can be more important than the health and well-being of the nation’s children? 

We, the undersigned health professionals and scientists, have huge concerns about the safety and necessity of Covid-19 vaccines for children, for reasons detailed in the letters enclosed. Between us, we have written numerous letters to the regulators, copied to your predecessor, regarding use of these mRNA products in children.  We call upon you, urgently, to pause the Covid-19 vaccine rollout for healthy under 18s, while a thorough and independent safety review is undertaken.  We urge you to reconsider their deployment for the following reasons:

  • Covid-19 was always a much milder illness in children, with a risk of death for otherwise healthy children of around 1 in 2 million. Successive variants have become less virulent, reducing the risk still further.
  • In addition, there is considerable evidence of rapidly waning vaccine efficacy, and increasing concerns over immediate vaccines injuries (such as myocarditis with its known potential for severe and possibly permanent cardiac damage). 
  • There is still a total lack of long-term safety data and the worrying rise in excess non-Covid deaths[1] in young males aged 15-19 years has yet to be explained. 
  • Lastly, the vast majority of children have already been exposed to SARS-CoV-2 repeatedly and have achieved demonstrably effective immunity, which is far superior to vaccine-induced immunity.

In short, the balance of benefit and risk, used to support the rollout of mRNA vaccines to the elderly and vulnerable in 2021, is inappropriate and inapplicable for children in 2022. 

Below are links to all the fully referenced letters we have written to the MHRA, the JCVI and the CMOs over the past sixteen months. The detailed questions posed have never been properly addressed by these regulators. You may be aware that members of the Pandemic Response All Party Parliamentary Group also wrote to the JCVI in January 2022, regarding the documented increase in all-cause mortality in 15-19-year-old males, again with no satisfactory reply addressing their concerns.

Groups of health professionals from around the world have similar concerns and indeed some countries have already paused children’s Covid-19 vaccines, particularly for those who have already had SARS-CoV-2 infection.  The Danish Minister of Health recently declared that vaccinating children had been a mistake and has withdrawn it for healthy children. It is gratifying to see that in the UK the vaccine rollout for healthy 5-11s has been discontinued last week, but this leaves 12-17-years-olds still in an unnecessary programme.

The health of the nation’s children is of paramount concern and must surely be a high priority for an incoming Prime Minister. You will no doubt be aware of Sir Christopher Chope’s tireless work on a Covid-19 Vaccine Damage Bill,pushing for proper and fair compensation for thousands of vaccine-damaged adults.  You cannot allow the risk of Covid-19 vaccine injuries in children, who stand to gain zero benefit from vaccination due to the overwhelming majority having already been infected, and who have therefore already acquired natural immunity.

We entreat you to apply the precautionary principle to the use of these products, which still have no long-term safety data and remain in Phase 3 clinical trials. The evidence of damage that this rushed policy is causing for children mounts daily. 

In addition to concerns about the physical risk to children posed by these mRNA products, we would also remind you of the acknowledged and significant psychological and educational damage to children which resulted from the school closures and masking requirements implemented by your predecessor.  We would ask that, as a matter of urgency, you make clear that school closures and masking of schoolchildren will not be repeated under your watch. 

At the beginning of your term as Prime Minister, you have a critical opportunity to prevent avoidable damage to children, and the inevitable outcry and backlash that will follow, by pausing the rollout with immediate effect, as well as bringing to an end all harmful covid restrictions in schools. This is a risk-free action.  Until then, the political and health risks of these damaging policies will only escalate. 

We eagerly await your response. 

Wishing you well in the challenging job you have ahead.

Yours sincerely,

Dr Rosamond Jones, MBBS, MD, FRCPCH, retired consultant paediatrician, 

on behalf of members of CCVAC (Children’s Covid Vaccines Advisory Council) and many others…

CCVAC members 
Professor Anthony J BrookesProfessor of Genomics and Health Data Science, University of Leicester
Professor Angus Dalgleish MD, FRCP, FRACP, FRCPath, FMed Sci, Principal, Institute for Cancer Vaccines & Immunotherapy (ICVI)
Professor Richard EnnosMA, PhD. Honorary Professorial Fellow, University of Edinburgh
Professor John FaircloughFRCS FFSEM, retired Honorary Consultant Surgeon
Professor Norman FentonCEng, CMath, PhD, FBCS, MIET, Professor of Risk Information Management, Queen Mary University of London
Prof Anthony FryerPhD, FRCPath, Professor of Clinical Biochemistry, Keele University 
Professor David LivermoreBSc, PhD, retired Professor of Medical Microbiology
Professor Dennis McGonaglePhD, FRCPI, Consultant Rheumatologist, University of Leeds
Professor Keith WillisonPhD, Professor of Chemical Biology, Imperial College, London
Lord MoonieMBChB, MRCPsych, MFCM, MSc, retired member of the House of Lords, former parliamentary under-secretary of state 2001-2003, former consultant in Public Health Medicine
Dr Sonia AllumMBChB, FRCA, Consultant anaesthetist
Julie AnnakinRN, Immunisation Specialist Nurse
Dr Abby AstleMBBChir, BA(Cantab), DCH, DGM, MRCGP, GP Principal, GP Trainer, GP Examiner
Dr Elyse Baril-GuerardMD, CCFP, MRCGP, General Practitioner
Dr Michael BazlintonMBCHB MRCGP DCH, General Practitioner
Dr David BellMBBS, PhD, FRCP(UK), Public Health Physician
Dr Mark A BellMBChB, MRCP(UK), FRCEM, Consultant in Emergency Medicine
Dr Michael D BellMBChB, MRCGP, retired General Practitioner
Dr Alan BlackMBBS, MSc, DipPharmMed, retired Pharmaceutical Physician
Dr David BrambleMBChB, MRCPsych, MD, Consultant Psychiatrist
Dr Emma BrierlyMBBS, MRCGP, General Practitioner
Kim BullFoundation Degree in Paramedic Science, Paramedic
Mr John BunniMBChB (Hons), Dip Lap Surg, FRCS [ASGBI Medal] – Consultant Colorectal and General Surgeon
Dr Elizabeth BurtonMB ChB, retired General Practitioner
Dr David CartlandMBChB, BMedSci, General practitioner
Dr Peter ChanBM, MRCS, MRCGP, NLP, General Practitioner, Functional medicine
Dr  Marco Chiesa, MD, FRCPsych, Consultant Psychiatrist, Visiting Professor
Michael CockayneMSc, PGDip, SCPHNOH, BA, RN, Occupational Health Practitioner
Dr Julie CoffeyMBChB, General Practitioner
RN, Specialist Nurse Practitioner, retired
Mr Ian F ComaishMA, BM BCh, FRCOphth, FRANZCO, Consultant Ophthalmologist
James CookNHS Registered Nurse, Bachelor of Nursing (Hons), Master of Public Health
Dr Clare Craig BMBCh, FRCPath, Diagnostic Pathologist
Dr David CritchleyBSc, PhD in Pharmacology, 32 years’ experience in Pharmaceutical R&D
Dr Sue de LacyMBBS MRCGP AFMCP UK, Integrative Medicine Doctor
Dr Jayne LM Donegan MBBS, DRCOG, DCH, DFFP, MRCGP, Homeopathic Practitioner
Dr Damien Downing MBBS, MRSB, private physician
Dr Jonathan EastwoodGeneral Practitioner, BSc MB ChB MRCGP
Dr Jonathan Engler MBChB, LlB (hons), DipPharmMed
Dr Elizabeth Evans MA(Cantab), MBBS, DRCOG, retired Doctor, Director UKMFA
Dr Christopher Exley PhD FRSB, retired professor in Bioinorganic Chemistry
Dr John Flack  BPharm, PhD, retired Director of Safety Evaluation at Beecham Pharmaceuticals, retired Senior Vice-president for Drug Discovery SmithKline Beecham
Dr Charles Forsyth MBBS, BSEM, Independent Medical Practitioner
Dr Simon Fox BSc, BMBCh, FRCP, Consultant in Infectious Diseases and Internal Medicine
Dr Jenny Goodman MA, MBChB, Ecological Medicine
Dr Ali Haggett Mental health community work, 3rd sector, former lecturer in the history of medicine 
David HalpinMB BS FRCS, Orthopaedic and trauma surgeon (retired)
Dr Catherine HattonMBChB, General Practitioner 
Mr Anthony HintonMBChB, FRCS, Consultant ENT surgeon, London
Dr Renée HoenderkampfGeneral Practitioner
Dr Andrew IsaacMB BCh, Physician, retired
Dr Steve JamesMBBS, MA, FRCA, FFICM, Critical Care Consultant
Dr Keith JohnsonBA, DPhil (Oxon), IP Consultant for Diagnostic Testing
Dr Pauline JonesMB BS, Retired General Practitioner
Dr Gemma KempMBBS, FRCPath, Consultant Forensic Pathologist
Dr Tanya KlymenkoPhD, FHEA, FIBMS, Senior Lecturer in Biomedical Sciences
Dr Charles LaneMA, DPhil, Molecular Biologist
Dr Branko LatinkicBSc, PhD, Molecular Biologist
Dr Caroline Lapworth MBChB General Practitioner
Dr Theresa LawrieMBBCh, PhD, Director, Evidence-Based Medicine Consultancy Ltd, Bath
Dr Jason LesterMRCP, FRCR, Consultant Clinical Oncologist
Dr Felicity LillingstoneIMD DHS PhD ANP, Doctor, Urgent Care, Research Fellow
Mr Malcolm LoudonMBChB, MD, FRCSEd, FRCS(Gen Surg), MIHM,VR, Consultant Surgeon
Katherine MacGilchristBSc (Hons), MSc, CEO/Systematic Review Director, Epidemica Ltd
Dr Geoffrey MaidmentMBBS, MD, FRCP, Consultant physician, retired
Ahmad K MalikFRCS(Tr & Orth) Dip Med Sport, Consultant Trauma & Orthopaedic Surgeon
Dr Ayiesha MalikMBChB, General Practitioner
Dr Kulvinder Singh ManikMBBS, General Practitioner
Dr Fiona MartindaleMBChB, MRCGP, General Practitioner
Dr Julie MaxwellMBBCh, MRCPCH, Associate Specialist Community Paediatrician
Dr S McBrideBSc(Hons) Medical Microbiology & Immunobiology, MBBCh BAO, MSc in Clinical Gerontology, MRCP(UK), FRCEM, FRCP(Edinburgh). NHS Emergency Medicine & geriatrics
Mr Ian McDermottMBBS, MS, FRCS(Tr&Orth), FFSEM(UK), Consultant Orthopaedic Surgeon
Dr Scott McLachlanFAIDH, MCSE, MCT, DSysEng, LLM, MPhil, Postdoctoral researcher
Dr Manjul MedhiMBChB MRCP DTM&H, Consultant in Infectious Disaeases and General Medicine
Dr Franziska MeuschelMD, ND, PhD, LFHom, BSEM, Nutritional, Environmental and Integrated Medicine
Dr Scott MitchellMBChB, MRCS, Emergency Medicine Physician
Dr Alan MordueMBChB, FFPH. Retired Consultant in Public Health Medicine & Epidemiology
Dr David MorrisMBChB, MRCP(UK), General Practitioner
Dr Claire MottramBSc Hons, MBChB, Doctor in General Practice
Margaret MossMA(Cantab), CBiol, MRSB, Director, The Nutrition and Allergy Clinic, Cheshire
Dr Alice MurkiesMD, FRACGP, MBBS, General Practitioner
Dr Greta MushetMBChB, MRCPsych, retired Consultant Psychiatrist in Psychotherapy
Dr Sarah MyhillMBBS, retired GP and Naturopathic Physician
Mr Colin NataliBSc(hons) MBBS, FRCS (Orth), Consultant Spinal Surgeon
Dr Chris NewtonPhD, Biochemist working in immuno-metabolism
Dr Rachel NichollPhD, Medical researcher
Dr Richard J O’SheaMBBCh, BA(Hons) MRCGP, General Practitioner
Sue Parker Hallcertified transactional analyst (CTA, psychotherapy); MSc (Counselling & Supervision) MBACP (senior accredited practitioner); EMDR practitioner, Psychotherapist
Dr Dean PattersonMBChB, FRCP, Consultant Cardiologist
Dr Christina PeersMBBS, DRCOG, DFSRH, FFSRH, Menopause specialist 
Rev Dr William J U PhilipMB ChB, MRCP, BD, Senior Minister The Tron Church, Glasgow, formerly physician specialising in cardiology
Anna PhillipsRSCN, BSc Hons, Clinical Lead Trainer Clinical Systems (Paediatric Intensive Care)
Dr Angharad PowellMBChB, BSc (hons), DFRSH, DCP (Ireland), DRCOG, DipOccMed, MRCGP, General Practitioner
Dr Gerry QuinnPhD. Postdoctoral researcher in microbiology and immunology
Dr Johanna ReillyMBBS, General Practitioner
Jessica RighartMSc, MIBMS, Senior Critical Care Scientist
Mr Angus RobertsonBSc, MB ChB, FRCSEd (Tr & Orth), Consultant Orthopaedic Surgeon
Dr Jessica RobinsonBSc(Hons), MBBS, MRCPsych, MFHom, Psychiatrist and Integrative Medicine Doctor
Dr Jon RogersMB ChB (Bristol), Retired General Practitioner
Mr James RoyleMBChB, FRCS, MMedEd, Colorectal surgeon 
Dr Salmaan SaleemMBBS, BMedSci, MRCGP, General Practitioner 
Dr Roland SalmonMB BS, MRCGP, FFPH, Former Director, Communicable Disease Surveillance Centre Wales
Sorrel ScottGrad Dip Phys, Specialist Physiotherapist in Neurology, 30 years in NHS
Dr Rohaan SethBSc (hons), MBChB (hons), MRCGP, Retired General Practitioner
Dr Haleema SheikhMRCGP, General Practitioner
Dr Gary Sidleyretired NHS Consultant Clinical Psychologist
Dr Annabel SmartMBBS, BSc, retired General Practitioner
Natalie StephensonBSc (Hons) Paediatric Audiologist 
Dr Zenobia StorahMA (Oxon), Dip Psych, DClinPsy, Senior Clinical Psychologist (Child and Adolescent) 
Dr Noel ThomasMA, MBChB, DCH, DObsRCOG, DTM&H, MFHom, retired doctor
Dr Stephen TingMB CHB, MRCP, PhD, Consultant Physician
Dr Julian TompkinsonMBChB MRCGP, General Practitioner, GP trainer PCME
Suzanne TomkinsonBSc, MSc, CSci, FIBMS, Senior Biomedical Scientist (Clinical Biochemistry)
Dr Livia Tossici-BoltPhD, Clinical Scientist
Dr Helen WestwoodMBChB, MRCGP, DCH, DRCOG, General Practitioner
Dr Carmen WheatleyDPhil, Orthomolecular Oncology
Mr Lasantha WijesingheFRCS, Consultant Vascular Surgeon
Dr Damian WildePhD, (Chartered) Specialist Clinical Psychologist
Dr Ruth WildeMB BCh, MRCEM, AFMCP, Integrative & Functional Medicine Doctor
Dr Lucie WilkMD, Consultant Rheumatologist
Dr Stefanie WilliamsMD, Dermatologist
Dr Holly YoungBSc, MBChB, MRCP, Consultant Palliative Care Medicine
  
Other signatoriesHealth professionals and scientists
Zuzana Herbst MantonRegistered Nurse
Dr M SyedaGeneral Practitioner, MRCGP
Jane Philebrown RGN, Triage/Practice Nurse
CharlotteOccupational Therapist
Rachelle brownPhysiotherapist
Caroline BrightRegistered Nurse-Theatres
Jonathan ClearyMBBS, MRCGP, FRACGP, FACRRM. General Practitioner 
Josephine TuckerSRN (retired)  and UKCP registered Psycotherapist (Self Employed)
Cristina GastaldiAcupuncture Pain Clinic 
Kelly AllenSenior Nursing Sister RNC
Suki ClarkeMidwife
EmmaMaternity HCA
JaneHealth Visitor Registered Nurse
Joanna BarkerRMN
Nikki TapalPhlebotomy manager
Natalia DayNurse
Dr Ross C WorthingtonSports Medicine, BM BCh
Amanda STANIERNurse RGN 
Kellie MorrissSenior Health Care Assistant/Student NA 
Amanda CairnsSCPHN MSc (OH)
Cassandra HamiltonStudent Nurse
Ellen Calteau Registered Dietitian HCPC registered 
Trudy GriffithsCare and support worker 
Julie TaskerComplementary Therapist and retired Tutor 
Jeanne Van der WeydenOccupational Health Nurse, Certificate in Tropical Diseases, Midwife (not practising)
Rosie RobertsPharmacy Technician
Ameena LewisNHS BLOODS TRANSPORT
Dr Neil K Gibbs BSc MPhil PhD FRSB, Biomedical Scientist  
Paul SeddonGeneral practitioner BSc MBBS DCH DRCOG DOcc Med MRCGP
Charlotte GowersOccupational Therapist 
Dr Graham MilneMB ChB, General Practitioner 
Dare MasonPsychotherapist, DipPsych, BSc
Paula CharnleyPsychotherapist
Dr Christian BucklandPsychotherapist, Psych(D), UKCP, MBACP, MUPCA
Vanessa ChurchillChiropractor/Homeopath, BSc (Chiro) DC LHM
Hilary HullTherapy Radiographer 
Louise PriestmanRegistered Nurse
Vicky NorrisCarer
David NashRegistered Nurse
Dr Rajendra SharmaMB BCh BAO LRCP&S(Ire) MFHom, Private Physician. 
Raine MarshallMental health nurse 
Samantha LomasCounsellor
Stephen JonesOccupational Therapist. BHSc (Hons) Occupational Therapy
Fiona CrowhurstRetired Registered General Nurse
Lynette DalyRetired Midwife 
Janice GiddyBA Hons Counselling. Retired staff counsellor NHS
Dr Kevin P CorbettRetired RN and PhD health scientist
Dr Robert John DurlingDental Surgeon
Kim Griffin 
Veronica De LucaSenior Nurse/Sister
Debbie WellsCardiac associate practitioner 
Nadina HoldenRN Adult & NICU Specialist BSc Hons
Sally Johns Green MBACPCounsellor/Play therapist, Diploma in Professional Studies
ElaineHaematology Sister 
Brian Howard D.O.Osteopath
Iain McWilliam LeithRetired GP then independent doctor
Ann Helena RobinsonHCA MRI and CT Scanning
Dr Emma Gillett DCChiropractor
Mrs Susan StanleySRN, SCM, (Retired Midwife)
Christina SpyratouSpecialist Registrar in Urology 
Dr Anne Catherine PriestleyRetired NHS GP MB BS, MRCP (UK).
Julia JacquesStaff nurse 
Catherine TurnerChartered Physiotherapist
Lucia BrunoNursing Associate 
KerryDental Nurse
JuliaRN Adult Nurse
Claire BuchananStaff nurse, DipHE nursing (child)
Rachel SimpsonSenior I MR/CT Radiographer – BSc (Hons) Diagnostic Radiography
Tiziana BertinottiDoctor of TCM, Acupuncture Clinician, BHSc (Acu), BA (Hons), PGCE
HeatherOccupational Therapist 
Jannah van der PolGeneral Practitioner
Tony RippingSenior Mental Health Practitioner (RMN)
Dr Gillian BreeseGeneral Practitioner BSc MB ChB DFFP DTM&H 
Dr Jessica EnglerTrainee GP, MBChB, BSc (Hons)
Sarah WatersPsychotherapist
Damien CominosParamedic
Penny SennerRegistered adult nurse. District nursing
Joanne HillRegistered Nurse, staff nurse NHS 
Hannah JanuszczykPharmacist
Ela BuzaljkoTrainee Nurse Assistant
June TranmerAcupuncturist – member of AAC
Jacqui CragoRadiographer. BAppSc (Medical Imaging)
Carol Fitzroy-BentLead Pharmacy Technician, BTech Pharmaceutical Sciences
Margaret StroudBDS, BSc (Hons)
Karen MooreRegistered Nurse
Joanne LeeDip NT 
Nichola DaviesRMN BSc Mental Health Nursing 
Dr Richard ScreenEmergency Medicine Doctor, MBChB, BSc (Hons)
Diane DoodySocial prescriber 
Helen HardwickSpecialist Nurse Critical Care, Bsc(Hons)Nursing Studies, Advanced Diploma in Psychotherapeutic Counselling
Evphi KalkanteraParkinsons Nurse Specialist 
Allison NichollsRegistered mental health nurse 
Christine CampbellCommunity nurse Degree
Sue CookClinic Director 
Dr Helen McArdleGeneral Practitioner, BSc (Hons) MBChB (Hons) MRCP, MRCGP, DRCOG, DipDerm
Mandy Sparks 
Suzanne Barlow 
Olivia Hene 
Yasmeen IslamSenior Staff Nurse
Fr Giles PinnockLead Hospital Chaplain
David WhiteMBChB retired GP
Emily WhewellPaediatric Nurse
Danielle Jayne LowesParamedic
Alan BairdRetired dentist, BDS
Theresa MounseyRegistered Midwife 
Dave MillardMental health nurse
Dr Azeezah IsaacsDentist BChD
Charles Abduraghmaan Dentist, BChD
Robert LarocheRegistered nurse
Kate HattonNurse Advisor RN, SCPHN
Ioana PelicanGeneral dental practitioner
Dr SaloniConsultant, MBBCh, PhD, BSc
Annabel Acheson-GrayPhysiotherapist in private practice 
Lisa WaddStroke Specialist, SLT BSc 
Tim GreenPhD Biochemist
Paul AscouParamedic
Gabriella HollandStudent of Naturopathic Nutrition
Jane FeeneyChild & Family Psychotherapist, MA psych
Ishah JohnsBand 6 Paediatric Nurse 
Wendy BabbidgeStaff Nurse 
Louise FergusonHealth Visitor – Specialist Community Public Health Nurse
Dr John HarrisonPhD, FDSRCSEng, FRCPath, Retired Consultant Pathologist
Claire E AdamRegistered nurse, BSc (Hons)
AlicjaMSc BioChem, ANutr
Dr John IsaacsMBChB, retired General Practitioner 
Julia HortonAdministrator, NHS trust 
Jonathan BroughtonSurgical care practitioner, registered Nurse BSC MSC
Allan Frederick RogersSenior Occupational Therapist, BSc (Hons)
Andrew WiddringtonClinical lead, sedationist, dental surgeon, BDS PGDip Sed
Jane LameyRetired District Nurse and Practice Nurse.
Helen Mary Hedderman 
Shereena HamiltonMental Health Support Worker 
Justine Millard-CaseRegistered General Nurse 
Julieann CurrieRNLD, RSCN 
Sarah ThorpeParamedic
Christine GristAdult Nurse DipHE
Demetrios Jimmy PellasRegistered nurse, independent Prescriber
Richard House, PhD, CPsycholChartered psychologist (BPS), retired Senior University Lecturer in Psychology (Roehampton) and psychotherapist
Anna DucharmeRetired General Practitioner
Helen AuburnNutritional therapist Dip ION 
Susan BedfordSpecialist Nurse, RGN
Magdalena Stasiak-horkanGeneral Practitioner
Fiona Jones BSc(hons) DipPreSci PGCert Med Ed, FRPharmS, Retired Clinical Pharmacist
Carolyn PoluninIntegrative Psychotherapist MSc in Private Practice
Simona PanaitescuPsychologist
Joyce KillerbyRetired Registered General  Nurse
Dr Ada Nelson-IyeMBChB
Michelle MasonMental Health Nurse RMN
Sheena FraserGeneral Practitioner
Natalie HardyPharmacy Technician NVQ 3 in Pharmacy Services
Mariana Ferreira ds Silva e SousaPhysiotherapist
Kristina ThistlethwaiteDental care professional 
W Gordon BrydonRetired Clinical Scientist PhD
Karen ThompsonStaff Nurse RGN
Nicholas Peter LeeDirector and RGN (OH SCPHN), BN (Hons), BSc (Hons)
Isabella Jane Ruth WatsonSRN SCM (retired)
Vasileios GrigoriouRGN
Miss K Hickenmidwife and licensed acupuncturist. 
Anne RenfrewMB,ChB retired obstetrician/gynaecologist and general practitioner
Simon WilliamsRetired Doctor
Nigel AddisonSpecialist Nurse Practitioner RGN, DipOH, MHSc
Andrew Philip WalkerBDS retired general dental practitioner
Philip AustinAdministration
LisaOccupational therapist 
Alex BakerAdult Nurse
Maria CapriMidwife
Sunita KarnikSpeech & Language Therapist (retired)
John SherwoodPharmacist BPharm MRPHARMS 
AnnaSpecialist Occupational Therapist
Hannah BarsonOccupational Therapist 
Samantha LeesClinical Nurse Specialist RMN
Kelly EdwardsRegistered Children’s Nurse
Joanna HarrisonNeuro Occupational Therapist Grad Diploma
Naomi RiddelCAMHS Consultant Psychiatrist, BSc, MSc, MBBCh, MRCPsych 
Elissa HarperStaff Nurse
Dr Hugh PollardRetired GP. MB BS DRCOG 
Lisa McGrowMidwife
Helen WoodOccupational therapist 
Janina IszattRGN
Anna Marie MacdooNursing
Maria HortonOccupational Therapist (BSc hons)
Wendy Kellettretired graduate nurse
Dr Ricky FreemanBM, General Practitioner 
Maud MalonePodiatrist
Dr Stephen MounceResearch Fellow, Expert in modelling, data science, RT-PCR
Stuart GuyHMHW, M(Res), RN – Lecturer in Nursing
Andrea HalewoodPsychotherapist, BACP
Dr Ross WorthingtonBM BCh retired General Practitioner
Dr Miles DavidsonMBChB,  General Practitioner  PCN Vaccination Lead
Dr Stuart MorganGeneral Practitioner, MBBS
Mr Colin PetherickFDS, MBBCh, Oral Surgeon 
Sandra Marks SRN SCM RHV, Rtd Health Visitor
Fiona MurdochPSA registered Acupuncturist
Anne JebbChartered Physiotherapist
Luke JezephNutritional Therapist BANT CNHC Dip CNM
Roger Meacock BVSc MRCVSVeterinarian and human practitioner
Sarah SilverLevel II Health & Nutrition
Nicola MasseyNutritional Consultant 
Damien Bush MRCVSDirector, Downs Veterinary Practice Ltd. RCVS Recignised Advanced Practitioner Small Animal Surgery
Claire WainwrightSenior Biomedical Scientist (retired)
Rosemary PoppittRegistered Nurse, Registered Midwife, BA Hons (retired)
Ann MillsRetired nurse 
Poppy BagleyRegistered Children’s Nurse
Dr Aileen O’Kane 
David PhillipsDentist,BDS Wales 1986
Millicent Rose MairsHealthcare Assistant
G FairlyBN Adult Nursing Oncology 
Dr David Owen YatesGeneral Practitioner
Rowena FelipeCNS for ACS/Angina
Judith HaldenSpeech and language therapist
Mary Jane LauiganOncology research nurse
L MolinaPaediatric Coordinator/Nurse
Sara DaleHomeopath – Advanced diploma in Homeopathy 
Abigail DrewBiomedical Scientist
Dr Michael Russell EvansMB ChB (Bristol) General Practitioner 
Amanda HenningPractice Nurse
Susannah RobinsonMBBS, BSc, MRCP, MRCGP, General Practitioner

Any additional UK health professionals are welcome to add their signatures via the link here.


[1] Updated analysis of deaths in males 15-19 years of age – HART (hartgroup.org)

Letter to UK health authorities, re: 6 month to 4 years Covid vaccines

Dr June Raine, CEO MHRA
Professor Lim Wei Shen, Chairman JCVI COVID-19 vaccines sub-committee
Professor Chris Whitty, Chief Medical Officer
Dr Jenny Harries, CEO, UKHSA
Hon.Sajid Javid, MP, Secretary of State for Health & Social Care

30th June 2022

Dear Dr Raine,

Re: Covid-19 vaccines for 6 months to 4 years age group

We are writing to you urgently concerning the announcement that the FDA has granted an Emergency Use Authorisation for both Pfizer and Moderna Covid-19 vaccines in preschool children.

We would urge you to consider very carefully the move to vaccinate ever younger and younger children against SARS-CoV-2, despite the gradual but significant reducing virulence of successive variants, the increasing evidence of rapidly waning vaccine efficacy, the increasing concerns over long-term vaccine harms, and the knowledge that the vast majority of this young age group have already been exposed to SARS-CoV-2 repeatedly and have demonstrably effective immunity. Thus, the balance of benefit and risk which supported the rollout of mRNA vaccines to the elderly and vulnerable in 2021, is totally inappropriate for small children in 2022. 

We also strongly challenge the addition of Covid-19 vaccination into the routine child immunisation programme,[i]despite no demonstrated clinical need, known and unknown risks (see below) and the fact that these vaccines still have only conditional marketing authorisation.

It is noteworthy that the Pfizer documentation[ii] presented to the FDA has huge gaps in the evidence provided: 

  • The protocol was changed mid-trial. The original 2-dose schedule exhibited poor immunogenicity with efficacy far below the required standard. A third dose was added by which time many of the original placebo recipients had been vaccinated.  
  • There was no statistically significant difference between the placebo and vaccinated groups in either the 6–23-month age group or the 2-4-year-olds even after the third dose. Astonishingly the results were based on just three participants in the younger age group (1 vaccinated and 2 placebo) and just seven participants in the older 2–4-year-olds (2 vaccinated and 5 placebo).   Indeed, for the younger age the confidence intervals ranged from minus 367% to plus 99%. The manufacturer stated that the numbers were too low to draw any confident conclusions. Moreover, these limited numbers come only from children infected more than 7 days after the third dose. 
  • Over the whole time period from the first dose onwards (see page 39 Tables 19 & 20), there were a total of 225 infected children in the vaccinated arm and 150 in the placebo arm, giving a calculated vaccine efficacy of only 25% (14% for the 6-23 months, and 33% for 2-4s).  
  • The additional immunogenicity studies against Omicron, requested by the FDA, only involved a total of 66 children tested one month after the third dose (see page 35).   

It is incomprehensible that the FDA considered that this represents sufficient evidence on which to base a decision to vaccinate healthy children.  When it comes to safety, the data is even thinner: only 1057 children, some already unblinded, were followed for just 2 months. It is noteworthy that Sweden and Norway are not recommending the vaccine for 5-11s and Holland is not recommending it for children who have already had Covid-19. The director of the Danish Health and Medicines Authority stated recently that with what is now known, the decision to vaccinate children was a mistake.[iii]

We summarise below the overwhelming arguments against this vaccination.

A.  Extremely low risk from Covid-19 to young children

  • In the whole of 2020 and 2021, not a single child aged 1-9 died where Covid-19 was the sole diagnosis on the death certificate, according to ONS data.[iv]
  • A detailed study in England from 1st March 2020 to 1st March 2021 found only 6 children under 18 years died with no comorbidities. There were no deaths aged 1-4 years.[v]
  • Children clear the virus more easily than adults.[vi]
  • Children mount effective, robust, and sustained immune responses.[vii]
  • Since the arrival of the Omicron variant, infections have been generally much milder. That is also true for unvaccinated under 5s.[viii]
  • By June 2022 it is now estimated that 89% of 1-4-year-olds had already had SARS-CoV-2 infection.[ix]
  • Recent data from Israel shows excellent long-lasting immunity following infection in children, especially in 5-11s.[x]

B.  Poor vaccine efficacy 

  • In adults it has become apparent that vaccine efficacy wanes steadily over time, necessitating boosters at regular intervals. Specifically, vaccine efficacy has waned more rapidly against the latest Omicron variants. 
  • In children vaccine efficacy has waned more rapidly in 5-11s than in 12-17s, possibly related to the lower dose used in the paediatric formulation. One study from New York showed efficacy against Omicron falling to only 12% by 4-5 weeks and to negative values by 5-6 weeks post second dose.[xi] 
  • In the Pfizer 0-4s trial,1 the efficacy after two doses fell to negative values, necessitating a change to the trial protocol. After a third dose there was a suggestion of efficacy from 7-30 days but there is no data beyond 30 days to see how quickly this will wane. 

C. Potential harms of Covid-19 vaccines for children

  • There has been great concern about myocarditis in adolescents and young adults, especially in males after the second dose, estimated at 1/2600 in active post marketing surveillance in Hong Kong.[xii] The emerging evidence of persistent cardiac abnormalities[xiii] in adolescents with post mRNA vaccine myopericarditis, as demonstrated by cardiac MRI at 3-8 months follow up, suggests this is far from ‘mild and shot-lived’.  The potential for longer term effects requires further study and calls for the strictest application of the precautionary principle in respect of the youngest and most vulnerable children.
  • Although post-vaccination myocarditis appears to be less common in 5-11-year-olds than older children, it is, none-the-less, increased over baseline.[xiv] 
  • In the Pfizer study 50% of vaccinated children had systemic adverse events, including irritability and fever. Diagnosis of myocarditis is much more difficult in younger children.[xv]  No troponin levels or ECG studies were documented. Even a vaccinated child in the trial, hospitalised with fever, calf pain and a raised CPK, had no report of D-dimers, antiplatelet antibodies or troponin levels.
  • In Pfizer’s 5-11s post-authorisation conditions, they are required to conduct studies looking for myocarditis and are not due to report results until 2027.
  • Of equal concern are, as yet unknown, negative effects on the immune system. In the 0-4s trial, only 7 children were described as having ‘severe’ Covid-19 – 6 vaccinated and 1 given placebo. Similarly, for the 12 children with recurrent episodes of infection, 10 were vaccinated against only 2 who received placebo. These are all tiny figures and much too small to rule out any adverse impact such as antibody dependant enhancement (ADE)[xvi]  and other impacts on the immune system.
  • Also unanswered is the question of Original Antigenic Sin.[xvii]  It is of note that in a large Israeli study, those infected after vaccination had poorer cover than those vaccinated after infection.[xviii]  In the Moderna trial, N antibodies were seen in only 40% of those infected after vaccination, compared to 93% of those infected after placebo.[xix] 
  • There is evidence of vaccine-induced disruption of both innate and adaptive[xx],[xxi] immune responses. The possibility of developing an impaired immune function would be disastrous for children, who have the most competent innate immunity, which by now has been effectively trained by the circulating virus.
  • Totally unknown is whether there will be any adverse effect on T-cell function leading to an increase in cancers.[xxii] 
  • Also, in terms of reproductive function, limited animal biodistribution studies showed lipid nanoparticles concentrate in ovaries and testes.[xxiii]  Adult sperm donors have showed a reduction in sperm counts particularly of motile sperm, falling by 3 months post-vaccination and remaining depressed at 4-5 months.[xxiv] 
  • Even for adults, concerns are rising that serious adverse events are in excess of hospitalisations from Covid-19.[xxv]

D. Informed consent

  • For 5-11s, the JCVI, in recommending a ‘non-urgent offer’ of vaccination, specifically noted the importance of fully informed consent with no coercion.[xxvi]
  • With the low uptake in this age group, the presence of ‘therapy dogs’,[xxvii] advertisements including superhero images[xxviii] and information about child vaccination protecting friends and family, all clearly run contrary to the concept of consent, fully informed and freely given.[xxix] 
  • The complete omission of information explaining to the public the different and novel technology used in Covid-19 vaccines compared to standard vaccines, and the failure to inform of the lack of any long-term safety data, borders on misinformation.[xxx]

E. Effect on public confidence 

  • Vaccines against much more serious diseases, such as polio and measles, need to be prioritised.[xxxi]  Pushing an unnecessary and novel, gene-based vaccine onto young children risks seriously undermining parental confidence in the whole immunisation programme. 
  • The poor quality of the data presented by Pfizer risks bringing the pharmaceutical industry into disrepute and the regulators if this product is authorised.

In summary, young healthy children are at minimal risk from Covid-19, especially since the arrival of the Omicron variant.  Most have been repeatedly exposed to SARS-CoV-2 virus, yet have remained well, or have had short, mild illness. As detailed above, the vaccines are of brief efficacy, have known short- to medium-term risks and unknown long-term safety. Data for clinically useful efficacy in small children are scant or absent.  In older children, for whom they are already licensed, they have been promoted via ethically dubious schemes to the potential detriment of other, and vital, parts of the childhood vaccination programme.

For a tiny minority of children for whom the potential for benefit clearly and unequivocally outweighed the potential for harm, vaccination could have been facilitated by restrictive licences.  Whether following the precautionary principle or the instruction to First Do No Harm, such vaccines have no place in a routine childhood immunisation programme.  

Professor Angus Dalgleish, MD, FRCP, FRACP, FRCPath, FMed Sci, Principal, Institute for

  Cancer Vaccines & Immunotherapy (ICVI)

Prof Anthony Fryer, PhD, FRCPath, Professor of Clinical Biochemistry, Keele University 

Professor David Livermore, BSc, PhD, Retired Professor of Medical Microbiology, UEA

Professor John Fairclough FRCS FFSEM retired Honorary Consultant Surgeon 

Lord Moonie,  MBChB, MRCPsych, MFCM, MSc, House of Lords, former parliamentary under-

  secretary of state 2001-2003, former consultant in Public Health Medicine

Dr Abby Astle, MA(Cantab), MBBChir, GP Principal, GP Trainer, GP Examiner

Dr Michael D Bell, MBChB, MRCGP, retired General Practitioner

Dr Alan Black, MBBS, MSc, DipPharmMed, Retired Pharmaceutical Physician

Dr David Bramble, MBChB, MRCPsych, MD, Consultant Psychiatrist

Dr Emma Brierly, MBBS, MRCGP, General Practitioner

Dr David Cartland, MBChB, BMedSci, General practitioner

Dr Peter Chan, BM, MRCS, MRCGP, NLP, General Practitioner, Functional medicine

  practitioner 

Michael Cockayne, MSc, PGDip, SCPHNOH, BA, RN, Occupational Health Practitioner

Julie Coffey, MBChB, General Practitioner 

John Collis, RN, Specialist Nurse Practitioner, retired

Mr Ian F Comaish, MA, BM BCh, FRCOphth, FRANZCO, Consultant Ophthalmologist

James Cook, NHS Registered Nurse, Bachelor of Nursing (Hons), Master of Public Health

Dr Clare Craig, BMBCh, FRCPath, Pathologist

Dr David Critchley, BSc, PhD in Pharmacology, 32 years’ experience in Pharmaceutical R&D

Dr Jonathan Engler, MBChB, LlB (hons), DipPharmMed

Dr Elizabeth Evans, MA(Cantab), MBBS, DRCOG, Retired Doctor

Dr John Flack, BPharm, PhD, retired Director of Safety Evaluation at Beecham Pharmaceuticals and retired Senior Vice-president for Drug Discovery SmithKline Beecham 

Dr Simon Fox, BSc, BMBCh, FRCP, Consultant in Infectious Diseases and Internal Medicine

Dr Ali Haggett, Mental health community work, 3rd sector, former lecturer in the history of

  medicine 

David Halpin, MB BS FRCS, Orthopaedic and trauma surgeon (retired)     

Dr Renée Hoenderkampf, General Practitioner

Dr Andrew Isaac, MB BCh, Physician, retired

Dr Steve James, Consultant Intensive Care 

Dr Keith Johnson, BA, DPhil (Oxon), IP Consultant for Diagnostic Testing

Dr Rosamond Jones, MBBS, MD, FRCPCH, retired consultant paediatrician

Dr Tanya Klymenko, PhD, FHEA, FIBMS, Senior Lecturer in Biomedical Sciences

Dr Charles Lane, MA, DPhil, Molecular Biologist

Dr Branko Latinkic, BSc, PhD, Molecular Biologist

Dr Felicity Lillingstone, IMD DHS PhD ANP, Doctor, Urgent Care, Research Fellow 

Dr Theresa Lawrie, MBBCh, PhD, Director, Evidence-Based Medicine Consultancy Ltd, Bath

Katherine MacGilchrist, BSc (Hons), MSc, CEO/Systematic Review Director, Epidemica Ltd.

Dr Geoffrey Maidment, MBBS, MD, FRCP, Consultant physician, retired

Ahmad K Malik FRCS (Tr & Orth) Dip Med Sport, Consultant Trauma & Orthopaedic Surgeon

Dr Kulvinder Singh Manik, MBBS, General Practitioner

Dr Fiona Martindale, MBChB, MRCGP, General Practitioner

Dr S McBride, BSc(Hons) Medical Microbiology & Immunobiology, MBBCh BAO, MSc in Clinical

  Gerontology, MRCP(UK), FRCEM, FRCP(Edinburgh). NHS Emergency Medicine & geriatrics

Mr Ian McDermott, MBBS, MS, FRCS(Tr&Orth), FFSEM(UK), Consultant Orthopaedic Surgeon

Dr Franziska Meuschel, MD, ND, PhD, LFHom, BSEM, Nutritional, Environmental and Integrated Medicine

Dr Scott Mitchell, MBChB, MRCS, Emergency Medicine Physician

Dr Alan Mordue, MBChB, FFPH. Retired Consultant in Public Health Medicine & Epidemiology

Dr David Morris, MBChB, MRCP(UK), General Practitioner

Margaret Moss, MA (Cantab), CBiol, MRSB, Director, The Nutrition and Allergy Clinic, Cheshire

Dr Alice Murkies, MD FRACGP MBBS, General Practitioner

Dr Greta Mushet, MBChB, MRCPsych, retired Consultant Psychiatrist in Psychotherapy

Dr Sarah Myhill, MBBS, retired GP and Naturopathic Physician

Dr Rachel Nicholl, PhD, Medical researcher

Sue Parker Hall, certified transactional analyst (CTA, psychotherapy); MSc (Counselling & 

  Supervision) MBACP (senior accredited practitioner); EMDR practitioner, Psychotherapist

Dr Christina Peers, MBBS, DRCOG, DFSRH, FFSRH, Menopause specialist 

Rev Dr William J U Philip MB ChB, MRCP, BD, Senior Minister The Tron Church, Glasgow,

  formerly physician specialising in cardiology

Dr Angharad Powell, MBChB, BSc (hons), DFRSH, DCP (Ireland), DRCOG, DipOccMed, 

 MRCGP, General Practitioner

Dr Gerry Quinn, PhD. Postdoctoral researcher in microbiology and immunology

Dr Johanna Reilly, MBBS, General Practitioner

Jessica Righart, MSc, MIBMS, Senior Critical Care Scientist

Mr Angus Robertson, BSc, MB ChB, FRCSEd (Tr & Orth), Consultant Orthopaedic Surgeon

Dr Jessica Robinson, BSc(Hons), MBBS, MRCPsych, MFHom, Psychiatrist and Integrative

 Medicine Doctor

Dr Jon Rogers, MB ChB (Bristol), Retired General Practitioner

Mr James Royle, MBChB, FRCS, MMedEd, Colorectal surgeon 

Dr Roland Salmon, MB BS, MRCGP, FFPH, Former Director, Communicable Disease

 Surveillance Centre Wales

Sorrel Scott, Grad Dip Phys, Specialist Physiotherapist in Neurology, 30 years in NHS

Dr Rohaan Seth, BSc (hons), MBChB (hons), MRCGP, Retired General Practitioner

Dr Gary Sidley, retired NHS Consultant Clinical Psychologist

Dr Annabel Smart, MBBS, retired General Practitioner

Natalie Stephenson, BSc (Hons) Paediatric Audiologist 

Dr Zenobia Storah, MA (Oxon), Dip Psych, DClinPsy, Senior Clinical Psychologist (Child and

  Adolescent)

Dr Julian Tompkinson, MBChB MRCGP, General Practitioner GP trainer PCME

Dr Noel Thomas, MA, MBChB, DCH, DObsRCOG, DTM&H, MFHom, retired doctor

Dr Stephen Ting, MB CHB, MRCP, PhD, Consultant Physician

Dr Livia Tossici-Bolt, PhD, Clinical Scientist

Dr Carmen Wheatley, DPhil, Orthomolecular Oncology

Dr Helen Westwood MBChB MRCGP DCH DRCOG, General Practitioner

Mr Lasantha Wijesinghe, FRCS, Consultant Vascular Surgeon

Dr Damian Wilde, PhD (Chartered) Specialist Clinical Psychologist

Dr Damian Wilde, PhD, (Chartered) Specialist Clinical Psychologist

Dr Ruth Wilde, MB BCh, MRCEM, AFMCP, Integrative & Functional Medicine Doctor

    and others …..


[i] NHS vaccinations and when to have them. https://www.nhs.uk/conditions/vaccinations/nhs-vaccinations-and-when-to-have-them/

[ii] EUA amendment request for Pfizer-BioNTech COVID-19 Vaccine for use in children 6 months through 4 years of age. Submitted to the FDA 15/06/2022. https://www.fda.gov/media/159195/download

[iii] Denmark admits – in retrospect we didn’t get much out of vaccinating the children. Report from a press conference 27-06-2022. https://europe-cities.com/2022/06/27/denmark-admits-in-retrospect-we-did-not-get-much-out-of-vaccinating-the-children/

[iv] COVID-19 Deaths and Autopsies Feb 2020 to Dec 2021, Table 1: Number of Deaths Where COVID-19 Was the Only Cause Mentioned on the Death Certificate, 1 February 2020 to 31 December 2021, by Sex and Age Group, England and Wales, Jan. 17, 2022, Office for National Statisticshttps://www.ons.gov.uk/aboutus/transparencyandgovernance/freedomofinformationfoi/covid19deathsandautopsiesfeb2020todec2021

[v] Smith C, Odd D, Harwood R et al. Deaths in Children and Young People in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data. Nature Medicine 28 (2022): 185–192,https://www.nature.com/articles/s41591-021-01578-1.pdf

[vi] Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke, et al., Systems Serology Detects Functionally Distinct Coronavirus Antibody Features in Children and ElderlyNature Communications 12, no. 2037 (2021), https://doi.org/10.1038/s41467-021-22236-7.

[vii] Alexander C. Dowell, Megan S. Butler, Elizabeth Jinks, et al., “Children Develop Robust and Sustained Cross-Reactive Spike-Specific Immune Responses to SARS-CoV-2 Infection,” Nat Immunol 23 (2022): 40–49, https://doi.org/10.1038/s41590-021-01089-8

[viii] Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. COVID infection severity in children under 5 years old before and after Omicron emergence in the US. Preprint. https://www.medrxiv.org/content/10.1101/2022.01.12.22269179v1.full.pdf

[ix] MRC Biostatistics Unit. Report on Nowcasting and Forecasting – 23rd June 2022. https://www.mrc-bsu.cam.ac.uk/now-casting/nowcasting-and-forecasting-23rd-June-2022/

[x] Patalon T & Maccabi KS. Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents. Preprint21/06/2022. https://www.medrxiv.org/content/10.1101/2022.06.20.22276650v1

[xi] Dorabawila V, Hoefer D, Bauer UE et al. Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant. Preprint 28/02/2022. https://www.medrxiv.org/content/10.1101/2022.02.25.22271454v1.full-text

[xii] Chua GT, KWan MYW, Chui CSL et al. Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. N Engl J Med 2022; 386: 394-396. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8767823/

[xiii] Schauer J, Buddhe S, Gulhabe A et al. Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis. J Pediatr 2022; 245: 233-7. https://doi.org/10.1016/j.jpeds.2022.03.032

[xiv] Su JR. COVID-19 vaccine safety updates: Primary series in children and adolescents ages 5–11 and 12–15 years, and booster doses in adolescents ages 16–24 years. ACIP meeting 05-01-2022. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022-01-05/02-COVID-Su-508.pdf

[xv] Cincinnati Children’s Hospital, Health Library. Myocarditis in Children. Myocarditis in Children | Symptoms, Causes, Treatment & Prognosis (cincinnatichildrens.org)

[xvi] Yahi N, Chahinian H, Fantini J. Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?. J Infect. 2021;83(5):607-635. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351274/ 

[xvii] Brown EL, Essigmann HT. Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19. mSphere 2021; 6(2): e00056-21. ttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546681/

[xviii] Goldberg Y, Mandel M, Bar-On YM et al. Protection and waning of natural and hybrid COVID-19 immunity. N Engl J Med 2022; 386: 2201-12. https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118946?articleTools=true

[xix] Follmann D, Janes HE, Buhule OD et al. Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial. Preprint 19-04-2022. https://www.medrxiv.org/content/10.1101/2022.04.18.22271936v1.full

[xx] Föhse FK, Geckin B, Overheul GJ et al. The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and 2 innate immune responses. Preprint 06-05-2021. https://doi.org/10.1101/2021.05.03.21256520

[xxi] Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food and Chemical Toxicology 2022; 164:113008. https://doi.org/10.1016/j.fct.2022.113008

[xxii] Singh N, Bharara Singh A. S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study. Transl Oncol. 2020;13(10):100814. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7324311/

[xxiii] Pfizer-bio-distribution-confidential-document-translated-to-english.pdf. https://www.naturalnews.com/files/Pfizer-bio-distribution-confidential-document-translated-to-english.pdf

[xxiv] Gat I,Kedem A, Dviri M et al. Covid-19 Vaccination BNT162b2 Temporarily Impairs Semen Concentration and Total Motile Count among Semen Donors. Andrology 2022;1–7. https://onlinelibrary.wiley.com/doi/epdf/10.1111/andr.13209

[xxv] Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan RM, Doshi P. Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials. Preprint 23-06-2022. https://ssrn.com/abstract=4125239

[xxvi] JCVI statement on vaccination of children aged 5 to 11 years old. 16-02-2022. https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-aged-5-to-11/jcvi-statement-on-vaccination-of-children-aged-5-to-11-years-old

[xxvii] Therapy dogs comfort children during Covid jabs. BBC News. 27-02-2022. https://www.bbc.co.uk/news/uk-england-wiltshire-60529628

[xxviii] Evans E. “Calling All Superhero Kids”: The Unethical Targeting of Young Children by the NHS with COVID-19 Vaccine Adverts. The Daily Sceptic 19-06-2022. https://dailysceptic.org/archive/calling-all-superhero-kids-the-unethical-targeting-of-young-children-by-the-nhs-with-covid-19-vaccine-adverts/

[xxix] NHS South East London Clinical Commissioning Group. FAQs – Vaccinating 5 to 11 year olds.  https://selondonccg.nhs.uk/what-we-do/covid-19/covid-19-vaccine/faqs/faqs-vaccinating-5-to-11-year-olds/

[xxx] What is in the vaccine and how does it work? | NHS. 30-04-2021. https://www.youtube.com/watch?v=zgtWpwkS9u4&list=PLnhASgDToTktp2HIjdyeo2fsI6Agcn1ul&index=6

[xxxi] Boyd C. Polio may be spreading in Britain for first time in 40 YEARS. Mail Online 23-06-2022. https://www.dailymail.co.uk/health/article-10938639/Polio-spreading-UK-time-40-years-Evolved-version-virus-London-sewage.html

FDA: do not ignore pathology studies 31.03.22

Thursday, 31 March, 2022

Dear members of the FDA vaccines committee,

RE: Pfizer Covid-19 mRNA vaccine EUA application for children aged 6 months to 4 years, returning to FDA in April

I urge you to please do not ignore the evidence from pathology studies.

Privately initiated by family members, devasted from their loss and seeking to know the truth, pathology studies have demonstrated a connection of the death with the vaccine; here some references from the UK [1,2], Italy [3,4], Germany [5] and USA [6].

I would like to draw your attention to the systematic work of pathologists Prof Burkhardt and Prof Land on tissue samples obtained from 19 autopsies, presented at the second Pathologist Conference in Germany on the 4th of December 2021 [5], which has demonstrated a communality across the pathological findings: vessels infiltrated by T-lymphocytes, brain vessels full of swollen endothelia cells desquamated from the walls, destroyed capillaries in liver and lungs, tissue changes with lymphocytes infiltration and accumulation in previously healthy organs including myocardium and pericardium.

In particular, I would like to bring to your attention the latest findings of Prof Burkhardt work [7], which have been disseminated this month. His immuno-histological investigation has succeeded in detecting the spike protein in the cells of vessel walls of the samples and, furthermore, to confirm its provenance from the vaccine as opposed to SARS-CoV 2 (e.g. excluding its provenance from a breakthrough infection).

This would constitute the first proof of the suspicion that the spike protein, expressed by our own cells under the genetic instructions of the mRNA or viral vector vaccines, is responsible for inducing the inflammation and destruction seen in the blood vessels and organ’s tissues.

These findings would obviously have enormous implications and need to be verified independently. I urge you to promote properly funded post-mortem and histopathological studies in connection with the deaths and damages associated with Covid-19 vaccines, and to incorporate in them the methodology described in [7]. Such studies would provide the ultimate, and much needed, evidence to answer the warring concerns surrounding these vaccines..

Finally, I urge you to reject the Pfizer’s EUA application for children of 6 months to 4 years old, in the light of lack of benefits and of immense risks posed to this age group. Primum non nocere.

Livia

Dr Livia Tossici-Bolt

Phd, Clinical Scientist

Member of the Children’s Covid Vaccine Advisory Council

References:

[1] https://www.bbc.co.uk/news/uk-england-tyne-58330796

[2] https://www.dailymail.co.uk/news/article-10233341/Musician-40-suffered-brain-haemorrhage-induced-AstraZeneca-Covid-vaccine-inquest-hears.html

[3] https://www.eventiavversinews.it/primo-esito-dellautopsia-per-la-morte-del-24enne-trentino-pochi-giorni-dopo-pfizer-confermata-lemorragia-cerebrale/

[4] https://www.ilfattoquotidiano.it/2022/01/28/camilla-canepa-le-indagini-i-medici-sapevano-che-aveva-fatto-il-vaccino-ma-non-lo-scrissero-nella-cartella-clinica/6471583/

[5] Gill et al “Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose” Arch Pathol Lab Med. 2022 Feb 14.
doi: 10.5858/arpa.2021-0435-SA.
https://pubmed.ncbi.nlm.nih.gov/35157759/

[6] Burkhardt and Land, “Are deaths and adverse health effects afterv vaccination against Covid-19 related in a pathologically detectable way?” Pathology Conference, December 4, 2021
https://pathologie-konferenz.de/en/

[7] Burkhardt, “Pathology of vaccine deaths and vaccine injuries. After the evidence now first proof”. March 11, 2022
https://pathologie-konferenz.de/en/

To all members of the FDA 29.04.22

29th March 2022

To all members of the FDA vaccines committee

Dear Colleagues,

Re: Pfizer Covid-19 mRNA vaccine EUA application for children aged 6 months to 4 years, returning to FDA in April 

We are a group of health professionals and scientists from the UK and we are writing to urge you to please reject the Pfizer application for Emergency Use Authorisation of the mRNA Covid-19 vaccines in children aged 6 months to 4 years. Although we are not American citizens, we take the liberty of approaching you in the awareness that your decision will have repercussion for children in our country, in Europe and across the world.

In the following, we invite you to consider the available evidence in evaluating the risk-benefit balance for this age group.

We all know from anecdotal evidence in everyday life and from the hard evidence of a vast body of published literature that, thankfully, healthy children and teenagers are resilient to the SARS-Cov2 virus. Their innate and adaptive immune systems have proven to be able to fight the virus brilliantly, demonstrating an excellent infection recovery rate close to 100% and extremely low risk of death in the absence of comorbidities. This has been observed consistently throughout the pandemic worldwide, as seen in the large studies in the UKGermany and USA.
A recent study published in the Lancet summarizes with clarity the mortality data collected across the world during the pre-vaccine era, confirming the J-shaped pattern of the Covid-19 infection fatality rate (IFR) versus age: with values vanishingly small for children and adolescents (the lowest death rate occurring at age 7 years), it shows unequivocally that Covid-19 poses virtually zero risk to healthy children.

Furthermore, the vast majority of children has already been exposed to the virus; certainly, this is the case for the UK. Their naturally acquired immunity has proven to be superior to that of adults, in terms of longer-lasting functional antibodies, better cellular response (T-cells) and enhanced recognition of variants.  Real world data, therefore, do not provide any evidence of an “emergency” for this age group.

We also would like to invite you to reflect on the results of the Pfizer clinical trial in children aged 6 months to four years, which have demonstrated a failed vaccine immunogenicity after both second and third doses.  Coupled with the real word data demonstrating a negative effectiveness of the mRNA Covid-19 vaccine in the next age group (5 to 11 years) after the emergence of the Omicron variant, it becomes practically impossible to find a rational justification for recommending this type of vaccination to children.

While there appears to be no benefit to be gained, the risks the Covid-19 vaccines pose to children are extremely alarming.

The observation of declining protection against infections, hospitalisations and deaths among the fully vaccinated raises the serious concern of a possible disruption of both innate and adaptive immune responses following repeated doses, temporally close to each other, which every time trigger the same humoral response to a now obsolete spike protein. The possibility of developing an impaired immune function would be disastrous for children, who have the most competent innate immunity, which by now has been effectively trained by the circulating virus.

The VAERS database, despite its passive surveillance nature and resulting under-reporting, presents an alarming safety profile for the Covid-19 vaccines in all age groups, in terms of both number and severity of the adverse reactions. The most serious and common injury thus far is that of myocarditis, which poses a grave risk for young children, particularly males, as its incidence has been observed to increase with decreasing age and with the second mRNA vaccine dose.  Perhaps the most accurate estimate of myocarditis incidence in adolescents (age 12 to 17 years)  comes from Hong Kong, where an active monitoring program has been in place since the vaccine rollout. The alarming finding of an incidence rate as high as 1 in 2,563 in males after the second dose has prompted the authorities to implement a single dose policy in this age group.  Extremely concerning also is the emerging evidence of persistent cardiac abnormalities in adolescents with post mRNA vaccine myopericarditis, as demonstrated by cardiac MRI at 3-8 months follow up. The potential for longer term effects requires further study and calls for prudence.

The information from the CDC at the conclusion of 2021 was concerning: during just 4 weeks, 4,249 adverse events were reported for children aged 5-11 with 100 listed as serious, 15 had increased troponin (12 confirmed to be myocarditis), 12 had seizures and 2 died. Since then, the number of reports of children deaths in the VAERS database has sadly increased, while a particularly disturbing case has been removed without a reason being provided:
https://openvaers.com/covid-data/child-reports/1975356
https://openvaers.com/covid-data/child-reports/2109625
https://openvaers.com/covid-data/child-reports/2152560
https://www.icandecide.org/ican_press/report-of-toddlers-death-disappears-from-vaers-and-cdc-has-no-records-as-to-why/

https://openvaers.com/covid-data/child-summaries

We imagine you are aware that the FDA authorization of the Covid-19 vaccine in children aged 6 months to 4 years, would likely result in the CDC adding it to the childhood schedule. It is painfully clear that this would serve the aim of Pfizer to obtain an indefinite liability protection, which would lead to vaccine mandates and widespread iatrogenic injury. It is likely that this regime will be exported to the UK and Europe.

You have the power to stop this. Please follow your conscience and your professional duty to do no harm. Please reject Pfizer’s EUA application for children of 6 months to 4 years old.

Sincerely,

Dr Livia Tossici-Bolt, PhD, Clinical Scientist

Dr Rosamond Jones, MD, FRCPCH, retired consultant paediatrician, chairman CCVAC

Mr Ian F Comaish, MA, BM BCh, FRCOphth, FRANZCO, Consultant ophthalmologist

Katherine MacGilchrist, BSc (Hons), MSc, CEO/Systematic Review Director, Epidemica Ltd.

Dr David Cartland, MBChB, BMedSci, General practitioner

Dr Elizabeth Evans, MA(Cantab), MBBS, DRCOG, Retired Doctor

Dr Angharad Powell, MBChB, BSc (hons), DFRSH, DCP (Ireland), DRCOG, DipOccMed, MRCGP, General Practitioner

Mr James Royle, MBChB, FRCS, MMedEd, Colorectal surgeon 

Dr Helen Westwood MBChB MRCGP DCH DRCOG, General Practitioner

Dr Geoffrey Maidment, MBBS, MD, FRCP, Consultant physician, retired

Dr Noel Thomas, MA, MBChB, DObsRCOG, DTM&H, MFHom, Retired Doctor

Dr Gerry Quinn, PhD, Microbiologist 

Dr David Critchley, BSc, PhD, 32 years in pharmaceutical R&D as a clinical research scientist

Dr Emma Brierly, MBBS, MRCGP, General Practitioner

Dr S McBride, BSc(Hons) Medical Microbiology & Immunobiology, MBBCh BAO, MSc in Clinical Gerontology, MRCP(UK), FRCEM, FRCP(Edinburgh). NHS Emergency Medicine & geriatrics

Mr Ian McDermott, MBBS, MS, FRCS(Tr&Orth), FFSEM(UK), Consultant Orthopaedic Surgeon

Professor Anthony J Brookes, Professor of Genomics & Health Data Science, University of Leicester

Dr Jayne LM Donegan, MBBS, DRCOG, DCH, DFFP, MRCGP, General Practitioner

Mr Anthony Hinton, MBChB, FRCS, Consultant ENT surgeon, London

Dr Keith Johnson, BA, D.Phil (Oxon), IP Consultant for Diagnostic Testing

Dr Michael D Bell, MBChB, MRCGP, retired General Practitioner

Dr Tanya Klymenko, PhD, FHEA, FIBMS, Senior Lecturer in Biomedical Sciences

Dr Elyse Baril-Guerard, MD, CCFP, MRCGP, General Practitioner

Dr Pauline Jones MB BS retired general practitioner 

Mr Ian F Comaish, MA, BM BCh, FRCOphth, FRANZCO, Consultant ophthalmologist

James Cook, NHS Registered Nurse, Bachelor of Nursing (Hons), Master of Public Health (MPH)

Dr Zac Cox, BDS, LCPH, Dentist

Dr Jon Rogers, MB ChB (Bristol), Retired General Practitioner

Rev Dr William J U Philip MB ChB, MRCP, BD, Senior Minister The Tron Church, Glasgow, formerly physician specialising in cardiology

Dr John Flack, BPharm, PhD. Retired Director of Safety Evaluation at Beecham Pharmaceuticals and retired Senior Vice-president for Drug Discovery SmithKline Beecham 

Dr Alan Mordue, MBChB, FFPH (ret). Retired Consultant in Public Health Medicine & Epidemiology

Julie Annakin, RN, Immunisation Specialist Nurse

Dr Christina Peers, MBBS, DRCOG, DFSRH, FFSRH, Menopause Specialist

Dr Carmen Wheatley, DPhil, Orthomolecular Oncology

Mr Angus Robertson, BSc, MB ChB, FRCSEd (Tr & Orth), Consultant Orthopaedic Surgeon

Dr Jenny Goodman, MA, MBChB, Ecological Medicine

Dr Kulvinder S. Manik MBChB, MRCGP, MA(Cantab), LLM, Gray’s Inn

David Halpin, MB BS FRCS, Orthopaedic and trauma surgeon (retired)   

Dr Charles Lane, Molecular Biologist 

Dr Stephen Ting, MB CHB, MRCP, PhD, Consultant Physician

Dr Sarah Myhill, MBBS, retired GP and Naturopathic Physician

Dr Felicity Lillingstone, IMD DHS PhD ANP, Doctor, Urgent Care, Research Fellow 

Dr Peter Chan, BM, MRCS, MRCGP, NLP, General Practitioner, Functional Medicine Practitioner, GP Trainer

Mr Lasantha Wijesinghe, FRCS, Consultant vascular surgeon

  …. and other members of the Children’s Covid Vaccine Advisory Council 

David Livermore

Professor David Livermore

David Livermore began his career in 1980 as Research Assistant at the London Hospital Medical College, writing a PhD ‘On the side’. By 1994 he’d risen to Senior Lecturer in Medical Microbiology. In 1997 he moved to the Public Health Laboratory Service, now Public Health England, swiftly becoming Director of its Antimicrobial Resistance Monitoring and Reference Laboratory. He remained until 2011, when he transferred to the University of East Anglia as Professor of Medical Microbiology.

Across 40 years he has belonged and led teams that have defined the evolving epidemiology and molecular nature of antimicrobial resistance.  He has authored over 500 papers and has served on UK government advisory committees on antimicrobial resistance and healthcare-infection.

John Flack

Dr John Flack, BPharm, PhD. 

John has 40 years experience in senior R&D and executive positions in pharmaceuticals and biotechnology. He attained a PhD in the Dept. of Pharmacology, School of Pharmacy, London University and a post-doctoral fellowship at the Worcester Foundation for Experimental Biology in Massachusetts, U.S.A.

He was Director of Safety Evaluation at Beecham Pharmaceuticals and Senior Vice-president for Drug Discovery at SmithKline Beecham, during which time nabumetone (an anti-inflammatory), paroxetine (an anti-depressant), granisetron (an anti-emetic), Eminase (a thrombolytic), Augmentin (an oral anti-bacterial), Timentin (an injectable anti-bacterial), penciclovir/famciclovir (injectable/oral antivirals), Bactroban (a topical anti-bacterial) were discovered, developed and registered for marketing.

More recently, John has volunteered at his local vaccination centre helping the NHS roll out COVID-19 vaccines in the community.

Critchley

David Critchley, BSc., PhD

David’s PhD in pharmacology was sponsored by Pfizer. He has more than 30 years experience in drug discovery and development in roles covering preclinical pharmacology, drug metabolism & pharmacokinetics and clinical pharmacology. He has worked on antiviral projects for HIV for Roche and has anti-infective experience in antiparasitic, antifungal and antibiotic drug discovery. As Eisai’s Global Head of Clinical Pharmacology he supported many new drug approvals including diethylcarbamazine (WHO), rufinamide, perampanel, zonisamide, lenvatinib and eribulin, as well as approvals for cannabidiol for the treatment of childhood epilepsy syndromes at GW.

  • 1
  • 2
Childrens union logo reversed small

Contact Us

© Children's Union. All rights reserved.